Following an initial investigation and risk mitigation proposal, Epsilon are pleased to announce a major investment award from a large generics company based on the south east coast. The project consists of reworking solid dose equipment that the company recently took over in order to ensure it all complied to current standards which required new controls, air handling systems, safety systems and full refurbishment of mixer granulators, fluid beds and tablet coaters. The project requires full ATEX certification due to the nature and extent of the modifications and the equipment will be CE marked, working with a Notified Body requires the additional development of technical information and formal risk assessment over and above the normally expected design qualification package. The work is expected to be completed in the first quarter of 2020 with a total value of over £500,000.
Supporting the World's Largest Orphan Charity